our results indicate that the frequency of phlebotomies in PV patients on HU does not represent a risk factor for future thrombosis in PV patients and do not support the need to shift from HU plus TP to second line drugs, and indirectly reinforce that a low HCT is the key variable to reduce the thrombotic risk in PV patients
No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from ECLAP and CYTO-PV clinical trials / Barbui, Tiziano; Carobbio, Alessandra; Ghirardi, Arianna; Masciulli, Arianna; Rambaldi, Alessandro; Vannucchi, Alessandro M.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - ELETTRONICO. - (2017), pp. 1-9. [10.3324/haematol.2017.165126]
No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from ECLAP and CYTO-PV clinical trials
VANNUCCHI, ALESSANDRO MARIA
2017
Abstract
our results indicate that the frequency of phlebotomies in PV patients on HU does not represent a risk factor for future thrombosis in PV patients and do not support the need to shift from HU plus TP to second line drugs, and indirectly reinforce that a low HCT is the key variable to reduce the thrombotic risk in PV patientsFile | Dimensione | Formato | |
---|---|---|---|
BARBUI_haematol.2017.165126.full.pdf
accesso aperto
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Creative commons
Dimensione
304.56 kB
Formato
Adobe PDF
|
304.56 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.